Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Boerner Christopher S.
Relationship:   Chief Executive Office...
City:   Bothell
State:   WA
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   173,563    

Indirect Shares

  0      
Direct Value   $21,090,213    

Indirect Value

  $0      
Total Shares   173,563      
Total Value   $21,090,213      


Seagen Inc
 $16,551,169 Bristol-Myers Squibb Co
 $4,539,044 Seagen Inc
 $16,551,169 Bristol-Myers Squibb Co
 $4,539,044
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    2   
    1    

     Stock price went up :

    0   
    1    
     Stock price went down :
    2   
    0    
   
     Gain/Loss Ratio :
   -2.0   
   1.0   
     Percentage Gain/Loss :
   -9.8%
 17.2%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Seagen Inc SGEN Executive Vice Preside... 2014-08-26 72,358 2011-08-19 0    Premium*  
            Bristol-Myers Squibb Co BMY Chief Executive Office... 2024-03-10 101,205 2019-02-02 0    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
BMY Bristol-Myers Squibb Co Chief Executive Officer   •       •      –    2024-03-10 4 D $53.79 $1,043,903 D/D (19,407) 101,205 0 -
BMY Bristol-Myers Squibb Co Chief Executive Officer   •       •      –    2024-03-10 4 D $0.00 $0 D/D (16,698) 115,180 0 -
BMY Bristol-Myers Squibb Co Chief Executive Officer   •       •      –    2024-03-10 4 OE $0.00 $0 D/D 54,638 129,769 0 -
BMY Bristol-Myers Squibb Co Chief Executive Officer   •       –      –    2023-12-05 4 B $49.78 $99,560 D/D 2,000 82,672 2.74 %
BMY Bristol-Myers Squibb Co Chief Executive Officer   •       –      –    2023-12-02 4 OE $0.00 $0 D/D 2,638 82,022 0 -
BMY Bristol-Myers Squibb Co Chief Executive Officer   •       –      –    2023-12-02 4 D $50.10 $67,635 D/D (1,350) 80,672 0 -
BMY Bristol-Myers Squibb Co Chief Executive Officer   •       –      –    2023-11-28 4 B $48.86 $150,049 D/D 3,071 79,384 2.74 %
BMY Bristol-Myers Squibb Co EVP, Chief Commercial Officer   •       –      –    2023-03-10 4 D $65.71 $2,274,880 D/D (34,620) 76,313 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Commercial Officer   •       –      –    2023-03-10 4 A $0.00 $0 D/D 8,568 96,086 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Commercial Officer   •       –      –    2023-03-10 4 OE $0.00 $0 D/D 59,111 91,880 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Commercial Officer   •       –      –    2022-12-02 4 D $81.13 $109,444 D/D (1,349) 43,254 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Commercial Officer   •       –      –    2022-12-02 4 OE $0.00 $0 D/D 2,637 44,603 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Commercial Officer   •       –      –    2022-03-14 4 S $69.20 $2,043,526 D/D (29,532) 41,966 0 %
BMY Bristol-Myers Squibb Co EVP, Chief Commercial Officer   •       –      –    2022-03-10 4 D $68.42 $2,363,569 D/D (34,545) 71,498 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Commercial Officer   •       –      –    2022-03-10 4 A $0.00 $0 D/D 13,417 94,282 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Commercial Officer   •       –      –    2022-03-10 4 OE $0.00 $0 D/D 51,715 81,649 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Commercial Officer   •       –      –    2022-03-10 4 A $0.00 $0 D/D 2,399 49,270 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Commercial Officer   •       –      –    2021-12-02 4 OE $0.00 $0 D/D 2,638 39,862 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Commercial Officer   •       –      –    2021-12-02 4 D $55.41 $74,804 D/D (1,350) 38,512 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Commercial Officer   •       –      –    2021-03-10 4 D $60.93 $783,011 D/D (12,851) 37,224 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Commercial Officer   •       –      –    2021-03-10 4 A $0.00 $0 D/D 2,643 42,818 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Commercial Officer   •       –      –    2021-03-10 4 OE $0.00 $0 D/D 25,215 41,325 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Commercial Officer   •       –      –    2021-03-10 4 D $0.00 $0 D/D (154) 25,022 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Commercial Officer   •       –      –    2020-12-02 4 D $62.18 $80,772 D/D (1,299) 22,371 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Commercial Officer   •       –      –    2020-12-02 4 OE $0.00 $0 D/D 2,637 23,670 0 -

  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed